Reportlinker finds all market research
reports published by official sources!

U.S. Biological Therapy Industry Analysis

  • This 74-page industry report was published in October 2011.
... as well as 278 Biological Therapy industry reports, company profiles and country guides published by official sources (government, embassies, trade unions...).

Privacy Policy by TRUSTe

We value your privacy and will never rent or sell your email address. Privacy Policy by TRUSTe

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Talk to Sam

(866) 682 9815

Share


Biological Therapy Industry in the United States : Latest Downloads

Cytokine Industry  in The United States and Europe

Cytokine Industry in The United States and Europe

  • Industry report
  • June 2012
  • 20 pages

... Regulations exist for am Annex 2 eu gmp guidelines: Special consideration should be given to quality of the starting materials, , Culture media, cytokines, growth factors and other additional substances ...

Biological Therapy in India and The United States : Innovation and Technology Trends

Biological Therapy in India and The United States : Innovation and Technology Trends

  • Industry report
  • June 2012
  • 30 pages

... It for phase iii clinical trials in india at 20 cancer centers. rnai based products will most likely be the first product to hit the market in the next 18-24 months with a high success rate and huge market ...

Biological Therapy in India and The United States : Innovation and Technology Trends

Biological Therapy in India and The United States : Innovation and Technology Trends

  • Industry report
  • June 2012
  • 30 pages

... Split as a result of them being bought out by other major pharma companie. Benefits Besides colorectal cancer, rnai based products can also be used in the treatment of other types of cancer ...


Related Market Segments :

Cytokine
Chemokine
Gm-csf
Dendritic Cell
Stem Cell

Biological Therapy Industry in the United States : Latest Reports

Immunotherapy in Oncology Drug Pipeline Update 2013

Immunotherapy in Oncology Drug Pipeline Update 2013

  • $ 3 675
  • Industry report
  • April 2013
  • by Bioseeker

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...

Cancer Stem Cells Drug Pipeline Update 2013

Cancer Stem Cells Drug Pipeline Update 2013

  • $ 2 249
  • Industry report
  • April 2013
  • by Bioseeker

Treatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and cancer drugs which ...

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013

  • $ 2 249
  • Industry report
  • April 2013
  • by Bioseeker

The androgen receptor signaling pathway activates the SMAD signaling module. There are today 313 companies plus partners developing 395 Androgen Receptor drugs in 1261 developmental projects in cancer. ...


Related Market Segments :

Cytokine
Chemokine
Gm-csf
Dendritic Cell
Stem Cell
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.